Logo IMG
HOME > My Amsci > Restricted Access

Restricted Access The content you've requested is available without charge only to active Sigma Xi members and American Scientist subscribers.

If you are an active member or an individual subscriber, please log in now in order to access this article.

If you are not a member or individual subscriber, you can:


Figure 6. Genes for strongly immunogenic tumor antigensClick to Enlarge Image

Vaccines to fight foreign invaders, such as viruses and bacteria, work by presenting the immune system with a harmless version of the pathogen that the immune system learns to recognize in case a person is faced with the real pathogen. Cancerous cells are not foreign. However, they are not entirely identical with their normal counterparts, either; they carry a set of proteins slightly different from those found on normal cells, and these can be exploited to develop vaccines that stimulate an immune response against them. As the authors explain, the DNA encoding these tumor-cell proteins can be injected into cells that might help people mount a vigorous immune response against the cancers.

Connect With Us:


Subscribe to Free eNewsletters!

Read Past Issues on JSTOR

JSTOR, the online academic archive, contains complete back issues of American Scientist from 1913 (known then as the Sigma Xi Quarterly) through 2005.

The table of contents for each issue is freely available to all users; those with institutional access can read each complete issue.

View the full collection here.

RSS Feed Subscription

Receive notification when new content is posted from the entire website, or choose from the customized feeds available.

Write for American Scientist

Review our submission guidelines.

Subscribe to American Scientist